Alpha Tau Medical (DRTS) Enterprise Value Growth (1y) (2021 - 2026)
Alpha Tau Medical (DRTS) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Alpha Tau Medical |
2,384.20 |
-76.42 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-48.00% |
| Dec 31, 2025 |
-22.69% |
| Sep 30, 2025 |
-10.72% |
| Jun 30, 2025 |
-12.20% |
| Mar 31, 2025 |
33.42% |
| Dec 31, 2024 |
27.13% |
| Sep 30, 2024 |
25.22% |
| Jun 30, 2024 |
24.72% |
| Mar 31, 2024 |
22.18% |
| Dec 31, 2023 |
21.76% |
| Sep 30, 2023 |
18.99% |
| Jun 30, 2023 |
16.37% |
| Mar 31, 2023 |
98.78% |
| Dec 31, 2022 |
-233.79% |
| Mar 31, 2022 |
-68,881.88% |
| Dec 31, 2021 |
31.94% |
